C-peptide is measured to differentiate endogenous (produced by the body) from exogenous (injected into the body) insulin production. When insulin is initially synthesized by the beta cells of the pancreas, it is produced as a large molecule (propeptide). This molecule is then cleaved at 2. The intermediate segment (C-peptide) is released at the same time insulin is released but has no known function.
The C-peptide level may be measured in a patient with type II diabetes mellitus to see if any insulin is still being produced endogenously. It may also be measured in the evaluation of hypoglycemia (low blood sugar) to see if too much insulin is being produced by the patient.
|